Ensysce Biosciences, Inc.(ENSC)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | GOWER BOB G Director | Purchase | +90,287 | +7.69%1,265,023 | $0.49 | $44,087 | View SEC filing | |
| 2023-03-02 | GOWER BOB G Director | Purchase | +379,300 | +47.68%1,174,736 | $0.48 | $182,350 | View SEC filing | |
| 2023-02-01 | GOWER BOB G Director | Purchase | +357,143 | +90.20%753,095 | $1.40 | $500,000 | View SEC filing | |
| 2022-05-27 | Kirkpatrick Lynn Chief Executive Officer | Purchase | +97,000 | +34.05%381,851 | $0.50 | $48,299 | View SEC filing | |
| 2020-06-23 | MORGAN STANLEY 10% Owner | Sale | -776,290 | -100.00%0 | N/A | N/A | View SEC filing | |
| 2018-01-17 | HG Vora Capital Management, LLC 10% Owner | Purchase | +1,000,000 | +40.61%3,462,500 | $10.00 | $10,000,000 | View SEC filing |
1-6 of 6